{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "d0d34dfb",
   "metadata": {},
   "outputs": [],
   "source": [
    "from transformers import pipeline\n",
    "from tqdm import tqdm\n",
    "import sys\n",
    "import json\n",
    "sys.path.append('../../')\n",
    "import globals\n",
    "\n",
    "fname = \"BioASQ-task11bPhaseB-testset3.json\"\n",
    "test_batch_doc = f'{globals.PATH.home}/data/11b_testset/{fname}'\n",
    "submission_file = json.load(open(test_batch_doc))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "707df3f1",
   "metadata": {},
   "outputs": [],
   "source": [
    "chat_gpt_fn = f'{globals.PATH.home}/data/11b_testset/11B_batch3_gpt.json'\n",
    "chat_gpt = json.load(open(chat_gpt_fn, \"r\"))\n",
    "chatgpt_questions = dict((elem['id'],elem) for elem in chat_gpt['questions'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "348c41c9",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "No model was supplied, defaulted to distilbert-base-cased-distilled-squad and revision 626af31 (https://huggingface.co/distilbert-base-cased-distilled-squad).\n",
      "Using a pipeline without specifying a model name and revision in production is not recommended.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "{'score': 0.914626955986023,\n",
       " 'start': 110,\n",
       " 'end': 149,\n",
       " 'answer': 'receiver operating characteristic curve'}"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "qa_model = pipeline(\"question-answering\")\n",
    "question = \"What is AUROC in context of predictive modeling?\"\n",
    "context = \"The predictive accuracy of an individual biomarker on cognitive impairment was evaluated using area under the receiver operating characteristic curve (AUROC), and multivariate logistic regression was applied to evaluate predictive accuracy of biomarkers on cognitive impairment; 178 subjects (41 PD, 31 VaD and 106 normal controls) were included.\"\n",
    "qa_model(question = question, context = context)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "87380066",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Is erenumab effective for trigeminal neuralgia?\n",
      "63f73f1b33942b094c000008\n",
      "[(0.16242441534996033, 'Erenumab did not reduce pain intensity'), (0.08406951278448105, 'further research is needed to determine the long-term efficacy'), (0.25706052780151367, 'erenumab has been found to be effective')]\n",
      "(0.25706052780151367, 'erenumab has been found to be effective')\n",
      "__________________________________\n",
      "What is the first indication for lurasidone?\n",
      "643d41e757b1c7a315000037\n",
      "[(0.8408240675926208, 'LatudaÂ®'), (0.9389773607254028, 'Lurasidone'), (0.7588313221931458, 'Lurasidone')]\n",
      "(0.9389773607254028, 'Lurasidone')\n",
      "__________________________________\n",
      "Can other vaccines be given with COVID-19 vaccine?\n",
      "643c88a257b1c7a315000030\n",
      "[(0.050089024007320404, 'randomly assigned (1:1)'), (0.08731797337532043, 'other vaccines can be given with the COVID-19 vaccine.'), (0.05235554650425911, 'other vaccines can be given with the COVID-19 vaccine')]\n",
      "(0.08731797337532043, 'other vaccines can be given with the COVID-19 vaccine.')\n",
      "__________________________________\n",
      "What is Sublocade?\n",
      "64403c4257b1c7a31500004f\n",
      "[(0.7924989461898804, 'a one-month-long depot formulation'), (0.33404606580734253, 'a prescription medication used to treat opioid use disorder'), (0.3459334671497345, 'a prescription medication used to treat opioid use disorder')]\n",
      "(0.7924989461898804, 'a one-month-long depot formulation')\n",
      "__________________________________\n",
      "Is music therapy effective for pain management in neonates?\n",
      "6441302d57b1c7a315000056\n",
      "[(0.020085426047444344, 'MT did not enhance the effect of pain relief of BF.'), (0.16420020163059235, 'Music therapy has been found to be an effective'), (0.2853524386882782, 'music therapy has been found to be effective')]\n",
      "(0.2853524386882782, 'music therapy has been found to be effective')\n",
      "__________________________________\n",
      "What is the mechanisms of action of Gilteritinib?\n",
      "63f042e2f36125a426000022\n",
      "[(0.00046532598207704723, 'transcriptional regulation'), (0.12303470820188522, 'helps to reduce the growth and spread of cancer cells'), (0.08016907423734665, 'blocking the activity of certain enzymes')]\n",
      "(0.12303470820188522, 'helps to reduce the growth and spread of cancer cells')\n",
      "__________________________________\n",
      "What is the reason for N-acetylgalactosamine (GalNAc) conjugation of siRNAs?\n",
      "64184483690f196b51000038\n",
      "[(0.8843657970428467, 'improved liver uptake'), (0.5249663591384888, 'improve the stability and delivery of siRNAs to target cells'), (0.29089081287384033, 'increase their stability and target delivery')]\n",
      "(0.8843657970428467, 'improved liver uptake')\n",
      "__________________________________\n",
      "What is synthetic lethality?\n",
      "643de76757b1c7a315000039\n",
      "[(0.22365570068359375, 'if mutation of either alone is compatible with viability'), (0.1720224916934967, 'two or more genetic mutations interact in a way that causes a cell to die'), (0.6495254635810852, 'a phenomenon in which two or more genetic mutations interact to cause cell death')]\n",
      "(0.6495254635810852, 'a phenomenon in which two or more genetic mutations interact to cause cell death')\n",
      "__________________________________\n",
      "How many injections of CLS-TA did the patients participating in the PEACHTREE trial receive?\n",
      "64403ab057b1c7a31500004d\n",
      "[(0.6864205002784729, 'two'), (0.7582360506057739, 'three'), (0.8999862670898438, 'three')]\n",
      "(0.8999862670898438, 'three')\n",
      "__________________________________\n",
      "What are the most commonly used diagnostic tests for the diagnosis of Duchenne muscular dystrophy?\n",
      "64179139690f196b5100002f\n",
      "[(0.2773440182209015, 'whole-exome sequencing'), (0.706130862236023, 'genetic testing, muscle biopsy, and electromyography (EMG)'), (0.05694931745529175, 'genetic testing')]\n",
      "(0.706130862236023, 'genetic testing, muscle biopsy, and electromyography (EMG)')\n",
      "__________________________________\n",
      "Is there any association between Tripe palms and cancer?\n",
      "63f02b50f36125a426000014\n",
      "[(0.17447884380817413, 'relatively rare'), (0.0978737324476242, 'some studies have suggested that there may be an association'), (0.2926150858402252, 'there is no scientific evidence')]\n",
      "(0.2926150858402252, 'there is no scientific evidence')\n",
      "__________________________________\n",
      "is prosopagnosia inherited or  acquired?\n",
      "6411b678201352f04a000036\n",
      "[(0.3902128040790558, 'acquired'), (0.35453546047210693, 'inherited or acquired'), (0.7146264910697937, 'acquired')]\n",
      "(0.7146264910697937, 'acquired')\n",
      "__________________________________\n",
      "Where are promoters typically found in DNA?\n",
      "643bc8f957b1c7a31500002b\n",
      "[(0.7173800468444824, \"directly upstream or at the 5' end of the transcription initiation site\"), (0.5290477275848389, 'upstream of the gene'), (0.6828077435493469, 'upstream')]\n",
      "(0.7173800468444824, \"directly upstream or at the 5' end of the transcription initiation site\")\n",
      "__________________________________\n",
      "What was the duration of the follow-up period of patients in the PEACHTREE clinical trial?\n",
      "64403be357b1c7a31500004e\n",
      "[(0.9814577102661133, '24 weeks'), (0.9850716590881348, '24 weeks'), (0.988731324672699, '24 months')]\n",
      "(0.988731324672699, '24 months')\n",
      "__________________________________\n",
      "Which are some symptoms of FSHD?\n",
      "644289c457b1c7a31500005e\n",
      "[(0.01500636525452137, 'facial, periscapular, foot dorsiflexor'), (0.3443898856639862, 'muscle weakness, muscle wasting, and difficulty with certain movements'), (0.08497371524572372, 'muscle weakness, pain, and wasting')]\n",
      "(0.3443898856639862, 'muscle weakness, muscle wasting, and difficulty with certain movements')\n",
      "__________________________________\n",
      "What is the mechanism of action of Adagrasib?\n",
      "63f02ec1f36125a426000017\n",
      "[(0.41880306601524353, 'irreversibly and selectively binds KRASG12C'), (0.3257099986076355, 'helps to reduce the risk of cardiovascular disease'), (0.3814016878604889, 'blocking the activity of a protein')]\n",
      "(0.41880306601524353, 'irreversibly and selectively binds KRASG12C')\n",
      "__________________________________\n",
      "Can Amyotrophic Lateral Sclerosis (ALS) be associated with a mutation of the Super Oxide Dismutase 1 (SOD) gene?\n",
      "641c516d690f196b5100003f\n",
      "[(0.06726193428039551, 'Approximately 2% of amyotrophic lateral sclerosis'), (0.010269719175994396, 'Recent research has suggested that a mutation'), (0.11080928891897202, 'ALS can be associated with a mutation of the SOD1 gene')]\n",
      "(0.11080928891897202, 'ALS can be associated with a mutation of the SOD1 gene')\n",
      "__________________________________\n",
      "What are enhancers?\n",
      "64371c5957b1c7a31500002a\n",
      "[(0.04890301078557968, 'not necessarily adjacent to target genes'), (0.5697091817855835, 'DNA sequences that can increase the expression of a gene'), (0.4888317883014679, 'DNA sequences that increase the rate of transcription of a gene')]\n",
      "(0.5697091817855835, 'DNA sequences that can increase the expression of a gene')\n",
      "__________________________________\n",
      "What is the mode of delivery of the drug XIPERE?\n",
      "6440396957b1c7a31500004b\n",
      "[(0.09248748421669006, 'targeting, compartmentalization, and durability of small molecule suspensions'), (0.8752870559692383, 'intravenously'), (0.9824360013008118, 'intravenous infusion')]\n",
      "(0.9824360013008118, 'intravenous infusion')\n",
      "__________________________________\n",
      "What are the most common muscular dystrophies?\n",
      "641791ca690f196b51000031\n",
      "[(0.06853201985359192, 'dystroglycanopathies'), (0.1019221767783165, 'Duchenne muscular dystrophy'), (0.19448000192642212, 'Duchenne muscular dystrophy, Becker muscular dystrophy')]\n",
      "(0.19448000192642212, 'Duchenne muscular dystrophy, Becker muscular dystrophy')\n",
      "__________________________________\n",
      "Which disease is targeted by Fazirsiran?\n",
      "63eef7eff36125a42600000e\n",
      "[(0.9575024247169495, 'Liver Disease'), (0.16488049924373627, 'primary hyperoxaluria type 1 (PH1)'), (0.7473353743553162, 'hyperoxaluria')]\n",
      "(0.9575024247169495, 'Liver Disease')\n",
      "__________________________________\n",
      "Where does Brain (or B type) Natriuretic Protein, BNP usually originate from?\n",
      "6431708a57b1c7a315000017\n",
      "[(0.15675467252731323, 'cultured cardiomyocytes'), (0.19088959693908691, 'the heart'), (0.708756685256958, 'the heart')]\n",
      "(0.708756685256958, 'the heart')\n",
      "__________________________________\n",
      "Are any medications available to prevent COVID-19 following exposure?\n",
      "643c396457b1c7a31500002d\n",
      "[(0.013688967563211918, 'This study did not meet the primary efficacy endpoint of post-exposure prevention'), (0.323419988155365, 'there are no'), (0.2966022193431854, 'there are currently no')]\n",
      "(0.323419988155365, 'there are no')\n",
      "__________________________________\n",
      "Has RTA 408 received FDA approval?\n",
      "6440092d57b1c7a315000040\n",
      "[(0.18400438129901886, 'FDA-approved'), (0.23623469471931458, 'The FDA has not yet approved RTA 408'), (0.4101995527744293, 'not')]\n",
      "(0.4101995527744293, 'not')\n",
      "__________________________________\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Which are the types of myotonic dystrophy?\n",
      "644291fa57b1c7a31500005f\n",
      "[(0.11594507098197937, 'DM type 2 (DM2)'), (0.02982873097062111, 'myotonic dystrophy type 2 (DM2)'), (0.892813503742218, 'type 1 (DM1) and type 2 (DM2)')]\n",
      "(0.892813503742218, 'type 1 (DM1) and type 2 (DM2)')\n",
      "__________________________________\n",
      "What are the active components of Opdualag?\n",
      "63f741a633942b094c000009\n",
      "[(0.16390417516231537, 'nivolumab AND relatlimab'), (0.7335296273231506, 'an opioid agonist and an opioid antagonist'), (0.01545773446559906, 'a workflow engine, a data analytics engine, an AI engine')]\n",
      "(0.7335296273231506, 'an opioid agonist and an opioid antagonist')\n",
      "__________________________________\n",
      "Where in the body would  Schlemm's canal be found\n",
      "640f8641201352f04a00002c\n",
      "[(0.002060363069176674, 'eyes treated with excisional LOTAIM'), (0.3556532561779022, 'the eye'), (0.4171258509159088, 'the eye')]\n",
      "(0.4171258509159088, 'the eye')\n",
      "__________________________________\n",
      "Can reinfection occur after SARS-CoV-2 infection?\n",
      "643c446357b1c7a31500002f\n",
      "[(0.19871865212917328, 'uncommon event'), (0.467922180891037, 'within a few months of initial infection'), (0.17922347784042358, 'rare')]\n",
      "(0.467922180891037, 'within a few months of initial infection')\n",
      "__________________________________\n",
      "What is the mode of inheritance of Friedreichâs ataxia?\n",
      "644009c557b1c7a315000041\n",
      "[(0.4746222496032715, 'autosomal recessive neurodegenerative disorder'), (0.5893473029136658, 'autosomal recessive disorder'), (0.42280393838882446, 'autosomal recessive disorder')]\n",
      "(0.5893473029136658, 'autosomal recessive disorder')\n",
      "__________________________________\n",
      "What is the difference between Duchenne muscular Dystrophy and Becker muscular dystrophy?\n",
      "641790a3690f196b5100002c\n",
      "[(0.4224509298801422, 'X-linked recessive disorders'), (0.3752579092979431, 'genetic disorders that cause progressive muscle weakness and wasting'), (0.2711368799209595, 'milder form that can affect both males and females')]\n",
      "(0.4224509298801422, 'X-linked recessive disorders')\n",
      "__________________________________\n",
      "What is Lance-Adams syndrome?\n",
      "63f56dc533942b094c000001\n",
      "[(0.5352550745010376, 'chronic post-hypoxic myoclonus'), (0.5813186764717102, 'a rare neurological disorder that affects the central nervous system'), (0.29376673698425293, 'a rare neurological disorder')]\n",
      "(0.5813186764717102, 'a rare neurological disorder that affects the central nervous system')\n",
      "__________________________________\n",
      "What does mitapivat do?\n",
      "643def7057b1c7a31500003a\n",
      "[(0.2733877897262573, 'increased the hemoglobin level'), (0.23541729152202606, 'helps to reduce the risk of cardiovascular events'), (0.3527735471725464, 'sharing experiences, knowledge, and resources with others')]\n",
      "(0.3527735471725464, 'sharing experiences, knowledge, and resources with others')\n",
      "__________________________________\n",
      "In prokaryotes, functionally related genes are sometimes positioned adjacent to each other in the genome and can be under the control of the same regulatory machinery. What are these called?\n",
      "64371a4257b1c7a315000029\n",
      "[(0.2686323821544647, 'operons'), (0.9766021966934204, 'operons'), (0.9975306987762451, 'operons')]\n",
      "(0.9975306987762451, 'operons')\n",
      "__________________________________\n",
      "What is the active ingredient of Xipere?\n",
      "6440377c57b1c7a315000049\n",
      "[(0.5498958826065063, 'triamcinolone acetonide'), (0.9808396100997925, 'azadirachtin'), (0.6079726815223694, 'Piper nigrum and Piper longum')]\n",
      "(0.9808396100997925, 'azadirachtin')\n",
      "__________________________________\n",
      "What are the most common mutation locations in dystrophin gene in Duchenne muscular dystrophy?\n",
      "64163568690f196b5100001b\n",
      "[(0.6484227180480957, '47, 48 and 50'), (0.9863094687461853, 'exon deletions'), (0.9907211065292358, 'exon deletions and duplications')]\n",
      "(0.9907211065292358, 'exon deletions and duplications')\n",
      "__________________________________\n",
      "Does mutation of ARTEMIS gene causes severe combined immunodeficiency?\n",
      "63ee5eeaf36125a426000002\n",
      "[(0.2689686715602875, 'Pathogenic variants'), (0.1092158779501915, 'Mutation'), (0.07465311884880066, 'can cause severe combined immunodeficiency')]\n",
      "(0.2689686715602875, 'Pathogenic variants')\n",
      "__________________________________\n",
      "Is Wilson's disease described as an iron storage disease?\n",
      "640c821c201352f04a000023\n",
      "[(0.04838196560740471, 'genetic copper storage disorder that causes hepatic and neurologic symptoms'), (0.4064679741859436, 'It is not'), (0.2420896291732788, 'not an iron storage disease')]\n",
      "(0.4064679741859436, 'It is not')\n",
      "__________________________________\n",
      "What are promoters?\n",
      "643c9b4057b1c7a315000032\n",
      "[(0.0584447868168354, 'a single transcription start site or a distinct cluster of start sites'), (0.3576373755931854, 'molecules that bind to specific sites on DNA'), (0.7040356993675232, 'regulatory regions of DNA that control the expression of genes')]\n",
      "(0.7040356993675232, 'regulatory regions of DNA that control the expression of genes')\n",
      "__________________________________\n",
      "Is omaveloxolone an activator of NFkB?\n",
      "6440084357b1c7a31500003e\n",
      "[(0.1155337393283844, 'activator of Nrf2'), (0.12384206056594849, 'activate the transcription factor NF-kB'), (0.2268013209104538, 'not an activator')]\n",
      "(0.2268013209104538, 'not an activator')\n",
      "__________________________________\n",
      "What is the most commonly used pain scale for the measurement of pain in children?\n",
      "6441057657b1c7a315000052\n",
      "[(0.040947895497083664, 'COMFORT Behavioural scale'), (0.5116598606109619, 'Faces Pain Scale-Revised'), (0.4838464856147766, 'Faces Pain Scale-Revised (FPS-R)')]\n",
      "(0.5116598606109619, 'Faces Pain Scale-Revised')\n",
      "__________________________________\n",
      "What is the mechanism of action of daridorexant?\n",
      "6402c71f201352f04a00000a\n",
      "[(0.23961631953716278, 'dual orexin receptor antagonist'), (0.12996461987495422, 'helps to promote sleep'), (0.28802305459976196, 'blocking the action of orexin')]\n",
      "(0.28802305459976196, 'blocking the action of orexin')\n",
      "__________________________________\n",
      "What is DILI-CAT used for?\n",
      "64257c9c690f196b5100004b\n",
      "[(0.03953114524483681, 'examine potential DILI in early phase ximelagatran clinical development'), (0.3201836943626404, 'to assess the risk of drug-induced liver injury in patients'), (0.5782347321510315, 'to assess the risk of drug-induced liver injury')]\n",
      "(0.5782347321510315, 'to assess the risk of drug-induced liver injury')\n",
      "__________________________________\n",
      "What is the significance of a persistently positive RT-PCR for weeks after illness?\n",
      "6429e1b857b1c7a315000008\n",
      "[(0.0012716067722067237, 'to determine if SARS-CoV-2 virus can be recovered'), (0.12994199991226196, 'to seek medical advice'), (0.17260919511318207, 'the virus is still present in the body')]\n",
      "(0.17260919511318207, 'the virus is still present in the body')\n",
      "__________________________________\n",
      "What is the genetic cause of Freidreich's ataxia?\n",
      "644029f857b1c7a315000042\n",
      "[(0.60182785987854, 'transcriptional silencing of the nuclear FXN gene'), (0.35570237040519714, 'FXN gene'), (0.2073894441127777, 'a mutation in the FXN gene')]\n",
      "(0.60182785987854, 'transcriptional silencing of the nuclear FXN gene')\n",
      "__________________________________\n",
      "Which diagnostic tests are used for the diagnosis of FSHD?\n",
      "6442869857b1c7a31500005d\n",
      "[(0.11024359613656998, 'Southern Blotting and hybridization to a set of probes'), (0.3546048402786255, 'electromyography (EMG), muscle biopsy, and genetic testing'), (0.6742371916770935, 'genetic')]\n",
      "(0.6742371916770935, 'genetic')\n",
      "__________________________________\n",
      "Can Efgartigimod be used for myasthenia gravis?\n",
      "64040d73201352f04a000010\n",
      "[(0.0841786190867424, 'well tolerated and efficacious'), (0.03405708074569702, 'approved by the FDA for the treatment of myasthenia gravis'), (0.47512680292129517, 'not approved')]\n",
      "(0.47512680292129517, 'not approved')\n",
      "__________________________________\n",
      "Have Quercetin-biapigenin nanoparticles been shown to be effective in penetrating the blood-brain barrier\n",
      "6422e7ba690f196b51000044\n",
      "[(0.1021961122751236, 'effective to penetrate the blood-brain barrier.'), (0.02203579992055893, 'Recent studies'), (0.05560276284813881, 'have been shown to be effective in penetrating the blood-brain barrier')]\n",
      "(0.1021961122751236, 'effective to penetrate the blood-brain barrier.')\n",
      "__________________________________\n",
      "What process involves metabolite-sensing mRNAs to control gene expression?\n",
      "6429e85e57b1c7a315000009\n",
      "[(0.8877888917922974, 'eukaryotic gene regulation'), (0.18456560373306274, 'binding of metabolites to the mRNA'), (0.047374699264764786, 'metabolite-sensing mRNAs controlling gene expression')]\n",
      "(0.8877888917922974, 'eukaryotic gene regulation')\n",
      "__________________________________\n",
      "What is ConcertaÂ®?\n",
      "6440360557b1c7a315000047\n",
      "[(0.42262032628059387, 'a methylphenidate formulation'), (0.09862319380044937, 'a prescription medication'), (0.32990512251853943, 'a prescription medication used to treat attention deficit hyperactivity disorder')]\n",
      "(0.42262032628059387, 'a methylphenidate formulation')\n",
      "__________________________________\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "What are the most common neuropsychiatric disorders associated with Duchenne muscular dystrophy?\n",
      "641794e7690f196b51000036\n",
      "[(0.018690751865506172, 'obsessive-compulsive disorder (OCD)'), (0.017811719328165054, 'anxiety, depression, attention-deficit/hyperactivity disorder'), (0.0599672868847847, 'anxiety, depression, attention deficit hyperactivity disorder')]\n",
      "(0.0599672868847847, 'anxiety, depression, attention deficit hyperactivity disorder')\n",
      "__________________________________\n",
      "Which interleukins are affected by Dupilumab?\n",
      "63ee5c78f36125a426000001\n",
      "[(0.2897609770298004, 'IL)-4 and IL-13'), (0.9879094362258911, 'IL-4 and IL-13'), (0.9790201783180237, 'IL-4 and IL-13')]\n",
      "(0.9879094362258911, 'IL-4 and IL-13')\n",
      "__________________________________\n",
      "What cells are used to regenerate cartilage?\n",
      "64316f8e57b1c7a315000016\n",
      "[(0.773239016532898, 'Mesenchymal stem cells'), (0.6978467106819153, 'Chondrocytes'), (0.9990328550338745, 'Chondrocytes')]\n",
      "(0.9990328550338745, 'Chondrocytes')\n",
      "__________________________________\n",
      "Is adenosine methylation an epigenetic modification?\n",
      "6429eb8457b1c7a31500000a\n",
      "[(0.09171681106090546, 'Epigenetic modifications have received increasing attention'), (0.20124009251594543, 'Adenosine methylation is an epigenetic modification'), (0.3240453600883484, 'adenosine methylation is an epigenetic modification')]\n",
      "(0.3240453600883484, 'adenosine methylation is an epigenetic modification')\n",
      "__________________________________\n",
      "Which year was XIPERE approved by the FDA?\n",
      "6440393157b1c7a31500004a\n",
      "[(0.9960696697235107, '2021'), (0.9975323677062988, '2018'), (0.9918393492698669, '2019')]\n",
      "(0.9975323677062988, '2018')\n",
      "__________________________________\n",
      "Can breastfeeding be used to alleviate the procedural pain in neonates?\n",
      "64412c2757b1c7a315000055\n",
      "[(0.03188319504261017, 'Non-pharmacological interventions'), (0.00885207112878561, 'Studies'), (0.16839905083179474, 'breastfeeding can be used to reduce the pain of procedures in neonates')]\n",
      "(0.16839905083179474, 'breastfeeding can be used to reduce the pain of procedures in neonates')\n",
      "__________________________________\n",
      "Can lenacapavir be used for HIV?\n",
      "64042000201352f04a000020\n",
      "[(0.01708996668457985, 'lenacapavir received its first approval in the EU'), (0.32477518916130066, 'it is being studied as a potential treatment for HIV.'), (0.22437362372875214, 'not used to treat HIV')]\n",
      "(0.32477518916130066, 'it is being studied as a potential treatment for HIV.')\n",
      "__________________________________\n",
      "What color light does the the inhibitory receptor halorhodopsin (eNpHR) respond to?\n",
      "6415b3b4690f196b51000009\n",
      "[(0.8967320322990417, 'yellow'), (0.9409171342849731, 'yellow-green'), (0.8722149133682251, 'yellow-green')]\n",
      "(0.9409171342849731, 'yellow-green')\n",
      "__________________________________\n",
      "What regulatory element promotes RNA polymerase II binding as well as the binding of factors that facilitate the unwinding of DNA prior to translation?\n",
      "6429fad757b1c7a31500000e\n",
      "[(0.40016353130340576, 'TATA\" box'), (0.6422224044799805, 'TATA box'), (0.5069100856781006, 'TATA box')]\n",
      "(0.6422224044799805, 'TATA box')\n",
      "__________________________________\n",
      "How many patients with Friedreich's ataxia were included in each cohort of the phase I/II double-blind, comparator-controlled trial of RT001.\n",
      "64402e7757b1c7a315000044\n",
      "[(0.4040527939796448, '9'), (0.5216724872589111, '48'), (0.6658944487571716, '24')]\n",
      "(0.6658944487571716, '24')\n",
      "__________________________________\n",
      "What is the incidence of Facioscapulohumeral Muscular Dystrophy?\n",
      "64425ce357b1c7a315000059\n",
      "[(0.39265528321266174, '1:8000'), (0.2015235275030136, '1 in 8,000 to 1 in 20,000 people worldwide'), (0.33438774943351746, '1 in 8,000 to 1 in 20,000 people worldwide')]\n",
      "(0.39265528321266174, '1:8000')\n",
      "__________________________________\n",
      "Risdiplam is used for treatment of which disease?\n",
      "63f581e933942b094c000007\n",
      "[(0.1812601536512375, 'Type 1 or 2 spinal muscular atrophy'), (0.6203232407569885, 'spinal muscular atrophy'), (0.7047469615936279, 'spinal muscular atrophy')]\n",
      "(0.7047469615936279, 'spinal muscular atrophy')\n",
      "__________________________________\n",
      "Please list the diseases associated with elevations in the plasma Neurofilament Light chain (NfL).\n",
      "641c5201690f196b51000040\n",
      "[(3.2385861459260923e-07, '(2) characterize the relationship between NfL level and kidney function'), (0.011131944134831429, 'a variety of neurological diseases'), (0.022659046575427055, \"Parkinson's disease, traumatic brain injury, and stroke.\")]\n",
      "(0.022659046575427055, \"Parkinson's disease, traumatic brain injury, and stroke.\")\n",
      "__________________________________\n",
      "What are the most common assays to profile chromatin accessibility?\n",
      "643c183b57b1c7a31500002c\n",
      "[(0.24824725091457367, 'Assay for Transposase Accessible Chromatin sequencing'), (0.00997036974877119, 'DNase-seq, ATAC-seq'), (0.015490571968257427, 'DNase-seq, ATAC-seq')]\n",
      "(0.24824725091457367, 'Assay for Transposase Accessible Chromatin sequencing')\n",
      "__________________________________\n",
      "What doses of RT001 were used in the phase I/II double-blind, comparator-controlled trial of Friedreich's ataxia patients?\n",
      "64402f6f57b1c7a315000045\n",
      "[(0.6291121244430542, '2'), (0.17566826939582825, 'two'), (0.45456042885780334, '0.5 mg/kg')]\n",
      "(0.6291121244430542, '2')\n",
      "__________________________________\n",
      "What are the most common pain scales used to measure pain in neonates?\n",
      "6440f85c57b1c7a315000051\n",
      "[(0.031553272157907486, 'The Neonatal Pain, Agitation, and Sedation Scale'), (0.06129011884331703, 'Premature Infant Pain Profile (PIPP)'), (0.09404075890779495, 'Premature Infant Pain Profile (PIPP)')]\n",
      "(0.09404075890779495, 'Premature Infant Pain Profile (PIPP)')\n",
      "__________________________________\n",
      "Was prehospital transdermal glyceryl trinitrate effective for stroke in the RIGHT-2 trial?\n",
      "6402c3fd201352f04a000009\n",
      "[(0.34746846556663513, 'does not seem to improve functional outcome in patients with presumed stroke'), (0.28674575686454773, 'not effective'), (0.10030905157327652, 'effective')]\n",
      "(0.34746846556663513, 'does not seem to improve functional outcome in patients with presumed stroke')\n",
      "__________________________________\n",
      "What gene is mutated in Friedreich's ataxia?\n",
      "6431f7de57b1c7a31500001b\n",
      "[(0.3193797171115875, 'frataxin'), (0.5591763854026794, 'FXN'), (0.5713851451873779, 'FXN gene')]\n",
      "(0.5713851451873779, 'FXN gene')\n",
      "__________________________________\n",
      "Is omaveloxolone a suppressor of Nrf2?\n",
      "643ff48a57b1c7a31500003d\n",
      "[(0.14711442589759827, 'an activator'), (0.18605339527130127, 'potent suppressor of Nrf2'), (0.25754091143608093, 'not a suppressor of Nrf2')]\n",
      "(0.25754091143608093, 'not a suppressor of Nrf2')\n",
      "__________________________________\n",
      "Can salivary cortisol be used to evaluate pain in neonates?\n",
      "64410f8057b1c7a315000054\n",
      "[(0.11875282973051071, 'SC'), (0.06797835230827332, 'can be used to evaluate pain in neonates'), (0.702268660068512, 'cannot')]\n",
      "(0.702268660068512, 'cannot')\n",
      "__________________________________\n",
      "Does nintedanib improve response rate in patients with bladder cancer?\n",
      "6402c0d5201352f04a000008\n",
      "[(0.3148987889289856, 'did not'), (0.2361219972372055, 'significantly improve response rate'), (0.3165035545825958, 'does not')]\n",
      "(0.3165035545825958, 'does not')\n",
      "__________________________________\n",
      "What is the difference between siRNA and Antisense oligonucleotide therapeutics\n",
      "6419fa3d690f196b5100003c\n",
      "[(0.48827505111694336, 'double-stranded small interfering RNA'), (0.20925039052963257, 'two types of RNA-based therapies used to treat genetic diseases'), (0.12869779765605927, 'double-stranded RNA molecule that binds to and silences specific mRNA molecules')]\n",
      "(0.48827505111694336, 'double-stranded small interfering RNA')\n",
      "__________________________________\n",
      "What is Yutiq?\n",
      "644036cf57b1c7a315000048\n",
      "[(0.1600242406129837, 'Preliminary evaluation'), (0.28122830390930176, 'prescription eye medication used to treat chronic non-infectious uveitis'), (0.461007297039032, 'prescription eye drop')]\n",
      "(0.461007297039032, 'prescription eye drop')\n",
      "__________________________________\n",
      "What is the incidence of Duchenne Muscular Dystrophy?\n",
      "643f9eeb57b1c7a31500003c\n",
      "[(0.8843141794204712, '1:5,000 live male births'), (0.3169364333152771, '1 in every 3,500 to 5,000 male births worldwide'), (0.37757623195648193, '1 in 3,500 to 5,000 male births')]\n",
      "(0.8843141794204712, '1:5,000 live male births')\n",
      "__________________________________\n",
      "Which drugs were studied in the TRICOTEL study?\n",
      "6402ba49201352f04a000004\n",
      "[(0.013177493587136269, 'cobimetinib'), (0.7970871925354004, 'telmisartan, rosuvastatin'), (0.0014931604964658618, 'telmisartan')]\n",
      "(0.7970871925354004, 'telmisartan, rosuvastatin')\n",
      "__________________________________\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "How is amniotic fluid produced?\n",
      "6431f6a857b1c7a315000018\n",
      "[(0.09900641441345215, 'by the flow of fluid from the fetal lung and bladder'), (0.167649045586586, 'by the fetus, the placenta, and the amniotic membrane'), (0.7002118229866028, 'by the fetal kidneys and lungs')]\n",
      "(0.7002118229866028, 'by the fetal kidneys and lungs')\n",
      "__________________________________\n",
      "Which cancer is the BCG vaccine used for?\n",
      "6415c252690f196b51000011\n",
      "[(0.4430887699127197, 'non-muscle invasive bladder cancer'), (0.5125412344932556, 'tuberculosis'), (0.8252717852592468, 'tuberculosis')]\n",
      "(0.8252717852592468, 'tuberculosis')\n",
      "__________________________________\n",
      "What are the most common congenital muscular dystrophies?\n",
      "641791b9690f196b51000030\n",
      "[(0.020207572728395462, 'dystroglycanopathies'), (0.03770307078957558, 'merosin-deficient CMD'), (0.047638148069381714, 'Duchenne muscular dystrophy, Becker muscular dystrophy')]\n",
      "(0.047638148069381714, 'Duchenne muscular dystrophy, Becker muscular dystrophy')\n",
      "__________________________________\n",
      "What disease can be treated with Teclistamab?\n",
      "63eeed0af36125a426000007\n",
      "[(0.3762231171131134, 'Relapsed or Refractory Multiple Myeloma'), (0.0980549231171608, 'lymphoma'), (0.2871586084365845, 'B-cell lymphoma')]\n",
      "(0.3762231171131134, 'Relapsed or Refractory Multiple Myeloma')\n",
      "__________________________________\n",
      "Please list the natriuretic peptides.\n",
      "643d3e6157b1c7a315000034\n",
      "[(0.015438750386238098, 'pro-atrial'), (0.01551929023116827, 'C-type natriuretic peptide (CNP)'), (0.03017781674861908, 'brain natriuretic peptide (BNP)')]\n",
      "(0.03017781674861908, 'brain natriuretic peptide (BNP)')\n",
      "__________________________________\n",
      "Does SRRM4 regulate neuronal-specific microexon splicing of TAF1 mRNA?\n",
      "63f9ee5c33942b094c000014\n",
      "[(0.2627929747104645, 'directly regulated'), (0.05126916989684105, 'SRRM4 is a splicing regulator'), (0.02192671224474907, 'SRRM4')]\n",
      "(0.2627929747104645, 'directly regulated')\n",
      "__________________________________\n",
      "What is the difference between Facioscapulohumeral Muscular Dystrophy type 1 (FSHD1) and type 2 (FSHD2)?\n",
      "644281e557b1c7a31500005b\n",
      "[(0.23138706386089325, 'phenotypically indistinguishable'), (0.5021399855613708, 'affects the muscles of the face, shoulders, and upper arms'), (0.16757524013519287, 'more common and typically presents with more severe symptoms')]\n",
      "(0.5021399855613708, 'affects the muscles of the face, shoulders, and upper arms')\n",
      "__________________________________\n",
      "SER-109 is developed for prevention of which disease?\n",
      "63f03ea0f36125a426000020\n",
      "[(0.6126044988632202, 'recurrent C. difficile infection'), (0.7563464045524597, 'recurrent Clostridioides difficile infection'), (0.943736732006073, 'Clostridioides difficile infection')]\n",
      "(0.943736732006073, 'Clostridioides difficile infection')\n",
      "__________________________________\n",
      "In twin-twin transfusion syndrome, are the twins identical?\n",
      "6431f71057b1c7a315000019\n",
      "[(0.7099237442016602, 'genetically identical'), (0.27535441517829895, 'they come from the same fertilized egg'), (0.37944021821022034, 'They share the same placenta')]\n",
      "(0.7099237442016602, 'genetically identical')\n",
      "__________________________________\n",
      "What is the definition of trichotillomania?\n",
      "6414c1ae690f196b51000003\n",
      "[(0.2883799076080322, 'an obsessive-compulsive or related disorder'), (0.6701302528381348, 'impulse control disorder'), (0.1524500846862793, 'a mental disorder')]\n",
      "(0.6701302528381348, 'impulse control disorder')\n",
      "__________________________________\n",
      "Where is the DMD gene located?\n",
      "64179113690f196b5100002e\n",
      "[(0.9480524659156799, 'Xp21'), (0.47979798913002014, 'X chromosome'), (0.47698774933815, 'X chromosome')]\n",
      "(0.9480524659156799, 'Xp21')\n",
      "__________________________________\n",
      "What is the mechanism of action of Tolebrutinib?\n",
      "64040c6b201352f04a00000f\n",
      "[(0.40980958938598633, 'covalently binds the kinase'), (0.058179471641778946, 'effective treatment for certain types of B-cell malignancies'), (0.4602496922016144, 'blocking the activity of BTK')]\n",
      "(0.4602496922016144, 'blocking the activity of BTK')\n",
      "__________________________________\n",
      "Optogenetics refers to the study of gene expression optimization\n",
      "6415b7b8690f196b5100000c\n",
      "[(0.016984140500426292, 'Optogenetics'), (0.11502164602279663, 'Optogenetics'), (0.1684790849685669, 'Optogenetics')]\n",
      "(0.1684790849685669, 'Optogenetics')\n",
      "__________________________________\n",
      "Which form of breast cancer has Keytruda been FDA approved for?\n",
      "6415c9e9690f196b51000018\n",
      "[(0.9001579284667969, 'pembrolizumab'), (0.47676506638526917, 'metastatic triple-negative'), (0.5114162564277649, 'metastatic triple-negative breast cancer')]\n",
      "(0.9001579284667969, 'pembrolizumab')\n",
      "__________________________________\n",
      "What is eteplirsen's mechanism of action?\n",
      "64178f94690f196b51000027\n",
      "[(0.528592050075531, 'exon-skipping therapy'), (0.13485187292099, 'targeting a specific mutation in the dystrophin gene'), (0.09342459589242935, 'skipping over a mutated exon')]\n",
      "(0.528592050075531, 'exon-skipping therapy')\n",
      "__________________________________\n",
      "Was DNX-2401 tested for treatment of Diffuse Intrinsic Pontine Glioma?\n",
      "63f03155f36125a426000019\n",
      "[(0.004841863643378019, 'in a clinical trial'), (0.19203388690948486, 'The drug has been tested in a Phase 1 clinical trial'), (0.22735503315925598, 'not been tested')]\n",
      "(0.22735503315925598, 'not been tested')\n",
      "__________________________________\n"
     ]
    }
   ],
   "source": [
    "fname = \"BioASQ-task11bPhaseB-testset3.json\"\n",
    "test_batch_doc = f'{globals.PATH.home}/data/11b_testset/{fname}'\n",
    "submission_file = json.load(open(test_batch_doc))\n",
    "\n",
    "for sample in submission_file['questions']:\n",
    "    context = \"\"\n",
    "    question = sample[\"body\"]\n",
    "    q_type = sample[\"type\"]\n",
    "    options = []\n",
    "    \n",
    "    for snippet in sample[\"snippets\"]:\n",
    "        context += snippet[\"text\"]\n",
    "        \n",
    "    res = qa_model(question = question, context = context)\n",
    "    options.append((res[\"score\"],res[\"answer\"]))\n",
    "    \n",
    "    shortans = chatgpt_questions[sample['id']]['ideal']\n",
    "    if len(shortans) > 5:\n",
    "        res = qa_model(question = question, context = shortans)\n",
    "        options.append((res[\"score\"],res[\"answer\"]))\n",
    "    \n",
    "    longans = chatgpt_questions[sample['id']]['short']\n",
    "    if len(longans) > 5:\n",
    "        res = qa_model(question = question, context = longans)\n",
    "        options.append((res[\"score\"],res[\"answer\"]))\n",
    "    \n",
    "    print(sample[\"body\"])\n",
    "    print(sample[\"id\"])\n",
    "    print(options)\n",
    "    best_ideal_ans = max(options,key=lambda item:item[0])\n",
    "    print(best_ideal_ans)\n",
    "    print('__________________________________')\n",
    "    sample[\"ideal_answer\"] = best_ideal_ans[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "43e3377b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "emoji is not installed, thus not converting emoticons or emojis into text. Install emoji: pip3 install emoji==0.6.0\n"
     ]
    }
   ],
   "source": [
    "from transformers import pipeline\n",
    "from transformers import AutoTokenizer, AutoModelForTokenClassification\n",
    "\n",
    "tokenizer = AutoTokenizer.from_pretrained(\"d4data/biomedical-ner-all\")\n",
    "model = AutoModelForTokenClassification.from_pretrained(\"d4data/biomedical-ner-all\")\n",
    "\n",
    "pipe = pipeline(\"ner\", model=model, tokenizer=tokenizer,aggregation_strategy='max') # pass device=0 if using gpu\n",
    "sentiment_model = pipeline(model=\"finiteautomata/bertweet-base-sentiment-analysis\")"
   ]
  },
  {
   "cell_type": "raw",
   "id": "c45fcfca",
   "metadata": {},
   "source": [
    "Dear Andres,\n",
    "\n",
    "We found a formatting issue in your submissions which prevented the evaluation from proceeding properly.\n",
    "In particular, the exact answers for factoid and list questions are provided as lists of strings \n",
    "(e.g. \"exact_answer\": [ \"a\",\"b\", \"c\", ...]) instead of lists of lists of strings \n",
    "(e.g. \"exact_answer\": [ [\"a\"],[\"b\"], ['c'], ...]).\n",
    "We fixed this issue for the evaluation to proceed properly, but please take this into account for your future submissions.\n",
    "\n",
    "Thank you for your participation, apologies for the inconvenience, and for any further details or support we remain at your disposal.\n",
    "\n",
    "Best wishes,\n",
    "\n",
    "Tasos"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "894870c6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'entity_group': 'Sign_symptom', 'score': 0.9999311, 'word': 'palpitations', 'start': 38, 'end': 50}, {'entity_group': 'Clinical_event', 'score': 0.99975544, 'word': 'follow', 'start': 54, 'end': 60}, {'entity_group': 'Date', 'score': 0.999867, 'word': '6 months after', 'start': 64, 'end': 78}]\n"
     ]
    }
   ],
   "source": [
    "res = pipe(\"\"\"The patient reported no recurrence of palpitations at follow-up 6 months after the ablation.\"\"\")\n",
    "print(res)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "1c0059b6",
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "for sample in submission_file['questions']:    \n",
    "    q_type = sample[\"type\"]\n",
    "    query = sample[\"ideal_answer\"]\n",
    "    \n",
    "    if q_type == 'yesno':\n",
    "        yesno_exact = chatgpt_questions[sample['id']]['exacta'] \n",
    "        sent = sentiment_model(query)[0]['label']\n",
    "        \n",
    "        if sent == 'NEG': \n",
    "            sample[\"exact_answer\"] = 'no'\n",
    "                \n",
    "        if sent == 'POS':\n",
    "            sample[\"exact_answer\"] = 'yes'\n",
    "                \n",
    "        if sent == 'NEU':\n",
    "            sample[\"exact_answer\"] = yesno_exact"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "d0f7ac08",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "What is the first indication for lurasidone?\n",
      "Lurasidone\n",
      "['lurasidone']\n",
      "['Major Depressive Disorder']\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "How many injections of CLS-TA did the patients participating in the PEACHTREE trial receive?\n",
      "three\n",
      "['three']\n",
      "['PEACHTREE trial', 'injections', 'CLS-TA', 'patients', 'confidence']\n",
      "\n",
      "What are the most commonly used diagnostic tests for the diagnosis of Duchenne muscular dystrophy?\n",
      "genetic testing, muscle biopsy, and electromyography (EMG)\n",
      "['genetic testing', 'muscle', 'electromyography']\n",
      "['Creatine Kinase Test', 'DNA Testing', 'Muscle Biopsy', 'Electromyography']\n",
      "\n",
      "\n",
      "is prosopagnosia inherited or  acquired?\n",
      "acquired\n",
      "['acquired']\n",
      "['Inherited', 'Acquired', 'Genetic', 'Hereditary', 'Congenital']\n",
      "\n",
      "Where are promoters typically found in DNA?\n",
      "directly upstream or at the 5' end of the transcription initiation site\n",
      "['upstream', \"the 5'end of the transcription initiation site\"]\n",
      "['Promoter', 'Transcription Start Site', 'Transcription Factor Binding Site', 'Core Promoter', 'Enhancer']\n",
      "\n",
      "What was the duration of the follow-up period of patients in the PEACHTREE clinical trial?\n",
      "24 months\n",
      "['24 months']\n",
      "['PEACHTREE Clinical Trial', 'Follow-up Period', 'Duration', 'Patients', 'Clinical Trials']\n",
      "\n",
      "Which are some symptoms of FSHD?\n",
      "muscle weakness, muscle wasting, and difficulty with certain movements\n",
      "['difficulty with', 'certain movements']\n",
      "['Muscle Weakness', 'Facial Droop', 'Difficulty Chewing/Swallowing', 'Scapular Winging', 'Foot Drop', 'Head Drop', 'Difficulty Climbing Stairs']\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "What is the mode of delivery of the drug XIPERE?\n",
      "intravenous infusion\n",
      "['intravenous infusion']\n",
      "['Oral', 'Tablet', 'Capsule', 'Liquid', 'Injection']\n",
      "\n",
      "What are the most common muscular dystrophies?\n",
      "Duchenne muscular dystrophy, Becker muscular dystrophy\n",
      "['muscular', 'becker', 'muscular dystrophy']\n",
      "['Duchenne Muscular Dystrophy', 'Becker Muscular Dystrophy', 'Limb-Girdle Muscular Dystrophy', 'Facioscapulohumeral Muscular Dystrophy']\n",
      "\n",
      "\n",
      "Where does Brain (or B type) Natriuretic Protein, BNP usually originate from?\n",
      "the heart\n",
      "['heart']\n",
      "['Cardiac Myocytes', 'Atrial Myocytes', 'Ventricular Myocytes', 'Ventricular Endocardium', 'Atrial Endocardium']\n",
      "\n",
      "\n",
      "\n",
      "Which are the types of myotonic dystrophy?\n",
      "type 1 (DM1) and type 2 (DM2)\n",
      "['type 1', 'type 2']\n",
      "['Myotonic Dystrophy Type 1', 'Myotonic Dystrophy Type 2']\n",
      "\n",
      "What are the active components of Opdualag?\n",
      "an opioid agonist and an opioid antagonist\n",
      "['opioid agonist', 'opioid antagonist']\n",
      "['Opioid', 'Acetaminophen']\n",
      "\n",
      "Where in the body would  Schlemm's canal be found\n",
      "the eye\n",
      "['eye']\n",
      "?\n",
      "\n",
      "Answer: Schlemm's Canal, Eye, Sclera, Cornea, Trabecular Meshwork\n",
      "\n",
      "\n",
      "What is the mode of inheritance of Friedreichâs ataxia?\n",
      "autosomal recessive disorder\n",
      "['autosomal recessive disorder']\n",
      "[\"Friedreich's Ataxia\", 'Autosomal Recessive Inheritance', 'Genetic Disorder', 'Genetic Mutations', 'Genes']\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "In prokaryotes, functionally related genes are sometimes positioned adjacent to each other in the genome and can be under the control of the same regulatory machinery. What are these called?\n",
      "operons\n",
      "['operons']\n",
      "1. Operons \n",
      "2. Co-regulated genes \n",
      "3. Transcriptional units \n",
      "4. Gene clusters \n",
      "5. Polycistronic mRNA\n",
      "\n",
      "What is the active ingredient of Xipere?\n",
      "azadirachtin\n",
      "['azadirachtin']\n",
      "['Xipere', 'Active Ingredient', 'Chemical Compound', 'Organic Compound', 'Molecule']\n",
      "\n",
      "What are the most common mutation locations in dystrophin gene in Duchenne muscular dystrophy?\n",
      "exon deletions and duplications\n",
      "['exon', 'deletions', 'duplications']\n",
      "['exon 51', 'exon 45', 'exon 44', 'exon 50', 'exon 53']\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "What is the most commonly used pain scale for the measurement of pain in children?\n",
      "Faces Pain Scale-Revised\n",
      "['pain', 'revised']\n",
      "1. Numerical Rating Scale (NRS) \n",
      "2. Faces Pain Scale-Revised (FPS-R) \n",
      "3. Wong-Baker FACES Pain Rating Scale \n",
      "4. Visual Analogue Scale (VAS) \n",
      "5. Color Analog Scale (CAS)\n",
      "\n",
      "\n",
      "What is DILI-CAT used for?\n",
      "to assess the risk of drug-induced liver injury\n",
      "['drug', 'induced', 'liver', 'injury']\n",
      "['Drug-Induced Liver Injury', 'Clinical Assessment Tool', 'Hepatotoxicity', 'Liver Injury', 'Drug Safety']\n",
      "\n",
      "\n",
      "\n",
      "Which diagnostic tests are used for the diagnosis of FSHD?\n",
      "genetic\n",
      "['genetic']\n",
      "['FSHD Genetic Test', 'EMG Test', 'MRI Test']\n",
      "\n",
      "\n",
      "\n",
      "What process involves metabolite-sensing mRNAs to control gene expression?\n",
      "eukaryotic gene regulation\n",
      "['eukaryotic gene regulation']\n",
      "1. mRNA \n",
      "2. Metabolite \n",
      "3. Gene Expression \n",
      "4. Metabolite-Sensing \n",
      "5. Control\n",
      "\n",
      "\n",
      "What are the most common neuropsychiatric disorders associated with Duchenne muscular dystrophy?\n",
      "anxiety, depression, attention deficit hyperactivity disorder\n",
      "['anxiety', 'attention deficit hyperactivity disorder']\n",
      "['Depression', 'Anxiety', 'Attention Deficit Hyperactivity Disorder (ADHD)', 'Behavioral Problems', 'Learning Disabilities']\n",
      "\n",
      "Which interleukins are affected by Dupilumab?\n",
      "IL-4 and IL-13\n",
      "['il - 4', 'il - 13']\n",
      "['Interleukin-4', 'Interleukin-13']\n",
      "\n",
      "What cells are used to regenerate cartilage?\n",
      "Chondrocytes\n",
      "['chondrocytes']\n",
      "['Chondrocytes']\n",
      "\n",
      "\n",
      "Which year was XIPERE approved by the FDA?\n",
      "2018\n",
      "['2018']\n",
      "['FDA', 'XIPERE', 'Food and Drug Administration', 'US Food and Drug Administration', 'US FDA']\n",
      "\n",
      "\n",
      "\n",
      "What color light does the the inhibitory receptor halorhodopsin (eNpHR) respond to?\n",
      "yellow-green\n",
      "['yellow', 'green']\n",
      "['Blue Light', 'Violet Light', 'Ultraviolet Light', 'Indigo Light', 'Green Light']\n",
      "\n",
      "What regulatory element promotes RNA polymerase II binding as well as the binding of factors that facilitate the unwinding of DNA prior to translation?\n",
      "TATA box\n",
      "['tata box']\n",
      "Answer: \n",
      "1. TATA box \n",
      "2. Initiator element \n",
      "3. CAAT box \n",
      "4. GC box \n",
      "5. BRE element\n",
      "\n",
      "How many patients with Friedreich's ataxia were included in each cohort of the phase I/II double-blind, comparator-controlled trial of RT001.\n",
      "24\n",
      "['24']\n",
      "1. RT001 \n",
      "2. Friedreich's Ataxia \n",
      "3. Phase I/II Double-Blind \n",
      "4. Comparator-Controlled Trial \n",
      "5. Patients\n",
      "\n",
      "What is the incidence of Facioscapulohumeral Muscular Dystrophy?\n",
      "1:8000\n",
      "['1', ': 8000']\n",
      "['Facioscapulohumeral Muscular Dystrophy', 'FSHD', 'Muscular Dystrophy', 'Duchenne Muscular Dystrophy', 'Myotonic Dystrophy']\n",
      "\n",
      "Risdiplam is used for treatment of which disease?\n",
      "spinal muscular atrophy\n",
      "['spinal muscular', 'atrophy']\n",
      "['Spinal Muscular Atrophy', 'Amyotrophic Lateral Sclerosis', 'Motor Neuron Disease', 'Muscular Dystrophy', 'Multiple Sclerosis']\n",
      "\n",
      "Please list the diseases associated with elevations in the plasma Neurofilament Light chain (NfL).\n",
      "Parkinson's disease, traumatic brain injury, and stroke.\n",
      "['parkinson', 'traumatic']\n",
      "['Amyotrophic Lateral Sclerosis', 'Multiple Sclerosis', \"Alzheimer's Disease\", \"Parkinson's Disease\", 'Traumatic Brain Injury']\n",
      "\n",
      "What are the most common assays to profile chromatin accessibility?\n",
      "Assay for Transposase Accessible Chromatin sequencing\n",
      "['transposase', 'chromatin sequencing']\n",
      "['DNase-seq', 'FAIRE-seq', 'ATAC-seq']\n",
      "\n",
      "What doses of RT001 were used in the phase I/II double-blind, comparator-controlled trial of Friedreich's ataxia patients?\n",
      "2\n",
      "['2']\n",
      "['2mg', '4mg', '6mg', '8mg']\n",
      "\n",
      "What are the most common pain scales used to measure pain in neonates?\n",
      "Premature Infant Pain Profile (PIPP)\n",
      "['premature infant pain profile', 'pipp']\n",
      "['Numeric Pain Scale', 'Neonatal Facial Coding System', 'Neonatal Infant Pain Scale', 'Premature Infant Pain Profile']\n",
      "\n",
      "\n",
      "What gene is mutated in Friedreich's ataxia?\n",
      "FXN gene\n",
      "['fxn', 'gene']\n",
      "['Friedreich Ataxia', 'FXN', 'FRDA', 'GAA', 'FXN gene']\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "What is the incidence of Duchenne Muscular Dystrophy?\n",
      "1:5,000 live male births\n",
      "['1', '5, 000', 'live', 'male births']\n",
      "['Duchenne Muscular Dystrophy', 'Muscular Dystrophy', 'Duchenne', 'Muscular Dystrophy Association', 'DMD']\n",
      "\n",
      "Which drugs were studied in the TRICOTEL study?\n",
      "telmisartan, rosuvastatin\n",
      "['telmisartan', 'rosuvastatin']\n",
      "['tacrolimus', 'sirolimus']\n",
      "\n",
      "\n",
      "Which cancer is the BCG vaccine used for?\n",
      "tuberculosis\n",
      "['tuberculosis']\n",
      "['Bladder Cancer', 'Lung Cancer', 'Gastric Cancer', 'Prostate Cancer', 'Colorectal Cancer']\n",
      "\n",
      "What are the most common congenital muscular dystrophies?\n",
      "Duchenne muscular dystrophy, Becker muscular dystrophy\n",
      "['muscular', 'becker', 'muscular dystrophy']\n",
      "['Duchenne Muscular Dystrophy', 'Becker Muscular Dystrophy', 'Congenital Muscular Dystrophy Type 1', 'Congenital Muscular Dystrophy Type 2', 'Limb-Girdle Muscular Dystrophy Type 1A', 'Fukuyama Congenital Muscular Dystrophy']\n",
      "\n",
      "What disease can be treated with Teclistamab?\n",
      "Relapsed or Refractory Multiple Myeloma\n",
      "['relapsed', 'refractory', 'multiple', 'myeloma']\n",
      "\n",
      "\n",
      "Please list the natriuretic peptides.\n",
      "brain natriuretic peptide (BNP)\n",
      "['brain natriuretic peptide', 'bnp']\n",
      "['Atrial Natriuretic Peptide (ANP)', 'Brain Natriuretic Peptide (BNP)', 'C-Type Natriuretic Peptide (CNP)']\n",
      "\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "SER-109 is developed for prevention of which disease?\n",
      "Clostridioides difficile infection\n",
      "['clostridioides', 'difficile', 'infection']\n",
      "Answer: [1] Malaria, [2] Dengue, [3] Zika, [4] Chikungunya, [5] Yellow Fever\n",
      "\n",
      "\n",
      "\n",
      "Where is the DMD gene located?\n",
      "Xp21\n",
      "['xp21']\n",
      "1. Chromosome X \n",
      "2. Xq21.2-q21.31 \n",
      "3. X-linked \n",
      "4. Duchenne Muscular Dystrophy \n",
      "5. Dystrophin\n",
      "\n",
      "\n",
      "\n",
      "Which form of breast cancer has Keytruda been FDA approved for?\n",
      "pembrolizumab\n",
      "['pembrolizumab']\n",
      "Answer: \n",
      "1. Triple-Negative Breast Cancer \n",
      "2. Metastatic Breast Cancer \n",
      "3. HER2-Positive Breast Cancer \n",
      "4. Advanced Breast Cancer \n",
      "5. Early-Stage Breast Cancer\n",
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "for sample in submission_file['questions']:    \n",
    "    q_type = sample[\"type\"]\n",
    "    query = sample[\"ideal_answer\"]\n",
    "\n",
    "    res = pipe(query)\n",
    "    entities = [ ent['word'] for ent in res ]\n",
    "    chatgpt_ents = chatgpt_questions[sample['id']]['exacta'] \n",
    "    \n",
    "    if q_type == 'list':\n",
    "        sample[\"exact_answer\"] = [ [e] for e in entities ]\n",
    "        print(sample['body'])\n",
    "        print(query)\n",
    "        print(entities)\n",
    "        print(chatgpt_ents)\n",
    "        \n",
    "    if q_type == 'factoid':\n",
    "        sample[\"exact_answer\"] =  [ [e] for e in entities ]\n",
    "        print(sample['body'])\n",
    "        print(query)\n",
    "        print(entities)\n",
    "        print(chatgpt_ents)\n",
    "    print()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "f8afba76",
   "metadata": {},
   "outputs": [],
   "source": [
    "name = f'{fname.replace(\".json\",\"\")}_ensamble.json'\n",
    "submission_file_name = f'{globals.PATH.home}/data/processed/{name}'\n",
    "\n",
    "with open(submission_file_name, \"w\") as outfile:\n",
    "    json.dump(submission_file, outfile, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "4d0028ec",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'/opt/bioasq/col-un-bioasq11/data/processed/BioASQ-task11bPhaseB-testset3_ensamble.json'"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "submission_file_name"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "b8a86152",
   "metadata": {},
   "source": [
    "# ChatGPT Submission"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "fa2a8010",
   "metadata": {},
   "outputs": [],
   "source": [
    "fname = \"BioASQ-task11bPhaseB-testset3.json\"\n",
    "test_batch_doc = f'{globals.PATH.home}/data/11b_testset/{fname}'\n",
    "submission_file = json.load(open(test_batch_doc))\n",
    "\n",
    "for sample in submission_file['questions']:\n",
    "    context = \"\"\n",
    "    question = sample[\"body\"]\n",
    "    q_type = sample[\"type\"]\n",
    "    options = []\n",
    "    \n",
    "    shortans = chatgpt_questions[sample['id']]['ideal']\n",
    "    if len(shortans) > 5:\n",
    "        res = qa_model(question = question, context = shortans)\n",
    "        options.append((res[\"score\"],res[\"answer\"]))\n",
    "    \n",
    "    longans = chatgpt_questions[sample['id']]['short']\n",
    "    if len(longans) > 5:\n",
    "        res = qa_model(question = question, context = longans)\n",
    "        options.append((res[\"score\"],res[\"answer\"]))\n",
    "    \n",
    "    if len(options) == 0:\n",
    "        for snippet in sample[\"snippets\"]:\n",
    "            context += snippet[\"text\"]      \n",
    "        res = qa_model(question = question, context = context)\n",
    "        options.append((res[\"score\"],res[\"answer\"]))\n",
    "        \n",
    "    best_ideal_ans = max(options,key=lambda item:item[0])\n",
    "    sample[\"ideal_answer\"] = best_ideal_ans[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "a6d2504b",
   "metadata": {},
   "outputs": [],
   "source": [
    "for sample in submission_file['questions']:    \n",
    "    q_type = sample[\"type\"]\n",
    "    query = sample[\"ideal_answer\"]\n",
    "    \n",
    "    if q_type == 'yesno':\n",
    "        yesno_exact = chatgpt_questions[sample['id']]['exacta'] \n",
    "        sample[\"exact_answer\"] = yesno_exact\n",
    "    \n",
    "        q_type = sample[\"type\"]\n",
    "        \n",
    "    query = sample[\"ideal_answer\"]\n",
    "\n",
    "    chatgpt_ents = chatgpt_questions[sample['id']]['exacta']\n",
    "    \n",
    "    if q_type == 'list':\n",
    "        sample[\"exact_answer\"] = [ [e] for e in chatgpt_ents ]\n",
    "        \n",
    "    if q_type == 'factoid':\n",
    "        sample[\"exact_answer\"] = [ [e] for e in chatgpt_ents ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "50f89e22",
   "metadata": {},
   "outputs": [],
   "source": [
    "name = f'{fname.replace(\".json\",\"\")}_chatgpt.json'\n",
    "submission_file_name = f'{globals.PATH.home}/data/processed/{name}'\n",
    "\n",
    "with open(submission_file_name, \"w\") as outfile:\n",
    "    json.dump(submission_file, outfile, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "7bc59207",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'/opt/bioasq/col-un-bioasq11/data/processed/BioASQ-task11bPhaseB-testset3_chatgpt.json'"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "submission_file_name "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9e85c274",
   "metadata": {},
   "source": [
    "# Without ChatGPT"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "83dc759f",
   "metadata": {},
   "outputs": [],
   "source": [
    "fname = \"BioASQ-task11bPhaseB-testset3.json\"\n",
    "test_batch_doc = f'{globals.PATH.home}/data/11b_testset/{fname}'\n",
    "submission_file = json.load(open(test_batch_doc))\n",
    "\n",
    "for sample in submission_file['questions']:\n",
    "    context = \"\"\n",
    "    question = sample[\"body\"]\n",
    "    q_type = sample[\"type\"]\n",
    "    options = []\n",
    "    \n",
    "    for snippet in sample[\"snippets\"]:\n",
    "        context += snippet[\"text\"]     \n",
    "        \n",
    "    res = qa_model(question = question, context = context)\n",
    "    options.append((res[\"score\"],res[\"answer\"]))\n",
    "\n",
    "    best_ideal_ans = max(options,key=lambda item:item[0])\n",
    "    sample[\"ideal_answer\"] = best_ideal_ans[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "36d28266",
   "metadata": {},
   "outputs": [],
   "source": [
    "for sample in submission_file['questions']:    \n",
    "    q_type = sample[\"type\"]\n",
    "    query = sample[\"ideal_answer\"]\n",
    "    \n",
    "    if q_type == 'yesno':\n",
    "        sent = sentiment_model(query)[0]['label']\n",
    "        \n",
    "        if sent == 'NEG': \n",
    "            sample[\"exact_answer\"] = 'no'\n",
    "                \n",
    "        if sent == 'POS':\n",
    "            sample[\"exact_answer\"] = 'yes'\n",
    "                \n",
    "        if sent == 'NEU':\n",
    "            sample[\"exact_answer\"] = 'yes'\n",
    "    \n",
    "    res = pipe(query)\n",
    "    entities = [ ent['word'] for ent in res ]\n",
    "    \n",
    "    if q_type == 'list':\n",
    "        sample[\"exact_answer\"] = entities[0:5]\n",
    "        \n",
    "    if q_type == 'factoid':\n",
    "        sample[\"exact_answer\"] = entities[0:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "c243ef61",
   "metadata": {},
   "outputs": [],
   "source": [
    "name = f'{fname.replace(\".json\",\"\")}_no_chatgpt.json'\n",
    "submission_file_name = f'{globals.PATH.home}/data/processed/{name}'\n",
    "\n",
    "with open(submission_file_name, \"w\") as outfile:\n",
    "    json.dump(submission_file, outfile, indent=2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "5cfc8a7a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'/opt/bioasq/col-un-bioasq11/data/processed/BioASQ-task11bPhaseB-testset3_no_chatgpt.json'"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "submission_file_name"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7dab5369",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "haystack-py310",
   "language": "python",
   "name": "haystack-py310"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
